Journals / The Anatolian Journal of Cardiology / 2016 / Cilt: 16 - Sayı: 2

Diagnostic performance of late gadolinium enhancement in the assessment of acute cellular rejection after heart transplantation

Pages
113–118
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

LGE and the history of ACR have no correlation.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Allograft rejection is still an important cause of morbidity and mortality after heart transplantation (HTx).
📊
Key Findings & Data:However, there is not enough information about late gadolinium enhancement (LGE) in the myocardium and ACR.Methods: We prospectively analyzed our consecutive 41 heart transplant recipients who were admitted for routine endomyocardial biopsies.
💡
Conclusion & Impact:LGE and the history of ACR have no correlation.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Allograft rejection is still an important cause of morbidity and mortality after heart transplantation (HTx). Many techniques in cardiac magnetic resonance imaging (CMR) were investigated to diagnose acute cellular rejection (ACR). However, there is not enough information about late gadolinium enhancement (LGE) in the myocardium and ACR.Methods: We prospectively analyzed our consecutive 41 heart transplant recipients who were admitted for routine endomyocardial biopsies. CMR was performed maximum 6 h before the scheduled endomyocardial biopsy. Correlation between LGE in the myocardium and ACR was investigated.Results: Twenty-seven patients showed no rejection, and nine of them had LGE in the myocardium. Fourteen patients had LGE in the left ventricle (LV), and two patients had LGE also in the right ventricle (RV). There was no correlation between LGE and ACR (p=0.879). There was no difference in the left ventricular ejection fraction (LVEF), right ventricular fractional area change (RVFAC), and cardiac ischemic time between the groups (p=0.825, p=0.370, and p=0.419, respectively). LGE in the myocardium could be due to previous rejection episodes; therefore, all patients were retrospectively searched for previous rejection grades and number of episodes. Thirty-eight of the 41 patients had a history of one ACR episode, but none of them had a statistically significant correlation with LGE (for grade 1R, p=0.964 and grade 3R, p=1) There was also no correlation between number of rejection episodes history and LGE.Conclusion: LGE is not suitable to detect ACR in heart transplant patients. LGE and the history of ACR have no correlation.

🔖

Cite This Article

ŞİMŞEK, E., NALBANTGİL, S., CEYLAN, N., ZOGHİ, M., KEMAL, H. S., ENGİN, Ç., YAĞDI, T., ÖZBARAN, M. (2016). Diagnostic performance of late gadolinium enhancement in the assessment of acute cellular rejection after heart transplantation. The Anatolian Journal of Cardiology, Cilt: 16 - Sayı: 2, 113–118. https://ajindex.com/articles/365449

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Stehlik J, Edwards LB, Kucheryavaya AY, Benden C, Christie JD, Dipchand AI, et al. The Registry of the International Society for Heart and Lung Transplantation: 29th official adult heart transplant report--2012. J Heart Lung Transplant 2012; 31: 1052-64.
  2. Lindenfeld J, Miller GG, Shakar SF, Zolty R, Lowes BD, Wolfel EE, et al. Drug therapy in the heart transplant recipient: part II: immuno- suppressive drugs. Circulation 2004; 110: 3858-65.
  3. Nair V, Butany J. Heart transplant biopsies: interpretation and sig- nificance. J Clin Pathol 2010; 63: 12-20.
  4. Stewart S, Winters GL, Fishbein MC, Tazelaar HD, Kobashigawa J, Abrams J, et al. Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejec- tion. J Heart Lung Transplant 2005; 24: 1710-20.
  5. Jimenez J, Kapadia SR, Yamani MH, Platt L, Hobbs RE, Rincon G, et al. Cellular rejection and rate of progression of transplant vascu- lopathy: a 3-year serial intravascular ultrasound study. J Heart Lung Transplant 2001; 20: 393-8.
  6. Yamani MH, Yousufuddin M, Starling RC, Tuzcu M, Ratliff NB, Cook DJ, et al. Does acute cellular rejection correlate with cardiac allograft vasculopathy? J Heart Lung Transplant 2004; 23: 272-6.
  7. Baraldi-Junkins C, Levin HR, Kasper EK, Rayburn BK, Herskowitz A, Baughman KL. Complications of endomyocardial biopsy in heart transplant patients. J Heart Lung Transplant 1993; 12: 63-7.
  8. Winters GL, Loh E, Schoen FJ. Natural history of focal moderate cardiac allograft rejection. Is treatment warranted? Circulation 1995; 91: 1975-80.
  9. Christen T, Shimizu K, Libby P. Advances in imaging of cardiac allograft rejection. Curr Cardiovasc Imaging Rep 2010; 3: 99-105.
  10. Jackson E, Bellenger N, Seddon M, Harden S, Peebles C. Ischaemic and non-ischaemic cardiomyopathies-cardiac MRI appearances with delayed enhancement. Clin Radiol 2007; 62: 395-403.
  11. Mahrholdt H, Wagner A, Judd RM, Sechtem U, Kim RJ. Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. Eur Heart J 2005; 26: 1461-74. Moon JC. What is late gadolinium enhancement in hypertrophic cardiomyopathy? Rev Esp Cardiol (English Version) 2007; 60: 1-4.
  12. Braggion-Santos M, Andre F, Lossnitzer D, Hofmann E, Simpfendörfer J, Dösch A, et al. Prevalence of different forms of infarct-atypical late gadolinium enhancement in patients early and late after heart transplantation. Clin Res Cardiol 2014; 103: 57-63.
  13. Kramer CM, Barkhausen J, Flamm SD, Kim RJ, Nagel E. Standardized c